Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Danaher Corporation

Danaher Corporation (DHR) Stock Overview

Explore Danaher Corporation’s financial performance, market position, analyst ratings, and future outlook.

DHR●NYSE
HealthcareMedical - Diagnostics & Research
$218.85
$2.94(1.36%)
U.S. Market opens in 59h 40m

Danaher Corporation (DHR)

Meyka AI Score

Z

Key Financials

Market Cap153.9B
P/E Ratio38.62
EPS (TTM)$7.98
ROE0.08%
Fundamental Analysis

AI Price Forecasts

1 Month$189.35
3 Months$204.19
1 Year Target$208.66

DHR Stock Analysis & Investment Overview (NYSE)

Our AI-powered analysis of Danaher Corporation (NYSE: DHR) gives investors deep insight into how the stock performs on the NYSE exchange, its growth potential, and its market positioning. With a Meyka AI Score of B+, Danaher Corporation's NYSE-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of DHR on the NYSE shows an RSI of 68.50, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $208.66 for the NYSE listing.

Key metrics behind Danaher Corporation's NYSE-traded stock include a P/E ratio of 38.62 and a market capitalization of 153.9B. Combined with our AI analysis, these give both institutional and retail investors a clear view of DHR on the NYSE.

Price Performance (NYSE: DHR)

1-Day Change
1.38%
5-Day Change
7.82%
1-Month Change
22.27%
3-Month Change
26.28%
6-Month Change
4.48%
Year-to-Date (YTD) Change
-4.39%
1-Year Change
7.35%
3-Year Change
-1.29%
5-Year Change
-22.50%
All-Time (Max) Change
36642.71%

Contact Information

https://www.danaher.com
202 828 0850
2200 Pennsylvania Avenue, NW, Washington, DC, 20037-1701

Company Facts

590,000 Employees
IPO DateDec 29, 1978
CountryUS
Actively Trading

Frequently Asked Questions